The early initiation of targeted antibiotic therapy in patients with bacteraemia and septic shock impacts favourably on outcomes. Rapid methods are therefore increasingly employed for bacterial identification directly from positive blood culture bottles, but with variable success. We evaluated the performance of the Gram Positive 12 multiplex tandem PCR (MT-PCR) assay (AusDiagnostics; catalogue no. 6202, version 07) containing targets for the identification of staphylococci including Staphylococcus aureus, streptococci including Streptococcus pneumoniae, enterococci including Enterococcus faecalis and Enterococcus faecium and their common antibiotic resistance genes (mecA, vanA, vanB). A total of 673 aerobic and anaerobic blood culture broths demonstrating Gram-positive cocci on microscopy were analysed in parallel with traditional phenotypic methods. Amplification of the internal control was inhibited in 79/673 (11.7 %) samples; however, MT-PCR identification was in concordance with phenotypic identification to the genus level in 96.6 % (537/556) of the remaining monomicrobial specimens and to the species level, where applicable, in 100 % (172/172) of samples. MT-PCR identification for 94.7 % (36/38) of polymicrobial samples matched traditional phenotypic identification. Meticillin and vancomycin susceptibility results determined by MT-PCR in blood culture broths demonstrated complete agreement with those determined by phenotypic methods in all 143 Staphylococcus aureus isolates and eight E. faecium isolates, respectively. Gram-positive pathogens and their key antibiotic resistance markers were reliably identified with the MT-PCR assay within 3 h of a positive blood culture result.
INTRODUCTION
Bacterial blood stream infections (BSIs) remain an important cause of morbidity and mortality worldwide (Bearman & Wenzel, 2005) . The time taken to initiate appropriate antibiotic therapy is an independent risk factor for mortality in association with a BSI (Retamar et al., 2012) , including BSIs due to Gram-positive organisms such as Staphylococcus aureus (Khatib et al., 2006; Paul et al., 2010) , Enterococcus species (Suppli et al., 2011) and Streptococcus pneumoniae (Garnacho-Montero et al., 2010) . Each hour of delay in the commencement of effective antibiotic therapy after the onset of hypotension in septic shock is associated with a decrease in survival, up to 7.6 % h 21 over the first 6 h (Kumar et al., 2006) .
The presence of the mecA gene reliably indicates high-level antibiotic resistance to meticillin and other beta-lactam antibiotics in Staphylococcus aureus (Deurenberg et al., 2007) . Six types of vancomycin resistance in enterococci have been characterized on a phenotypic and genotypic basis, with five of these types (VanA, B, D, E and G) corresponding to acquired resistance. Of the genes involved in resistance, only two (vanA and vanB) are common in clinically important species (Courvalin, 2006) . In Australia, the majority of vancomycin-resistant enterococci (VRE) clinical isolates are Enterococcus faecium containing the gene vanB (Johnson et al., 2010) .
Empiric antibiotic choice for bacteraemia is generally guided by the Gram stain performed after the initial detection of growth in blood culture bottles within automated incubators. Organism identification and antibiotic sensitivity results obtained through traditional phenotypic methods follow 24-72 h later, enabling changes to be made to the antibiotic cover to target the specific pathogen(s) isolated. Identification and susceptibility reports may take even longer to finalize for organisms with fastidious growth requirements and those that are difficult to identify.
Previous studies have demonstrated the potential utility of rapid identification systems such as fluorescent in situ hybridization and RT-PCR assays in the identification of organisms and detection of antibiotic resistance directly from positive blood culture bottles (Paule et al., 2005; Peters et al., 2006) . However, these assays have not been widely adopted for routine specimen processing, largely due to concerns regarding high assay costs, complicated methods or the narrow spectrum of organisms and antibiotic resistance targets detected.
Matrix-assisted laser desorption/ionization time-of-flight MS is emerging as another rapid technique for the direct identification of organisms from blood culture broths, with results available within 2 h (Christner et al., 2010; Kok et al., 2011) . Likewise, the direct inoculation of growthpositive blood culture broth into automated biochemical typing systems has been described to reduce reporting turnaround times (Chen et al., 2008; Gherardi et al., 2012) . However, both of these methods appear to perform less well in the identification of Gram-positive organisms as compared with that of Gram-negative organisms (Chen et al., 2008; Prod'hom et al., 2010; Kok et al., 2011; Gherardi et al., 2012) .
In this study we evaluated the performance of the Gram Positive 12 multiplex tandem PCR (MT-PCR) assay by AusDiagnostics in the identification of common Grampositive bacteria and antibiotic resistance genes carried by organisms in the genera Staphylococcus, Streptococcus and Enterococcus from positive blood cultures.
METHODS
Study overview. From February to October 2010, positive blood culture broths (BD BACTEC Plus Aerobic/F, Lytic/10 Anaerobic/F and PEDS Plus/F media; Becton Dickinson) identified by the BACTEC FX blood culture system, with Gram-positive cocci apparent upon Gram staining, were prospectively analysed using the Gram Positive 12 MT-PCR assay. Results were compared with standard phenotypic identification methods performed in parallel.
Phenotypic identification methods. A 5 ml aliquot of broth was aspirated from growth-positive blood culture bottles. Aliquots were centrifuged at 1250 g for 15 min in a serum-separating tube, the supernatant was aspirated and the leukocyte-rich buffy coat was retained. A Gram stain was performed on the resuspended buffy coat layer and then approximately 1 ml was used for direct inoculation of horse blood, chocolate and MacConkey agars. These plates were incubated at 37 uC in CO 2 or O 2 for 18-24 h. Blood-haemin-vitamin K medium was also inoculated and incubated anaerobically for 48 h. All media used in this study were produced in-house in our laboratory's media production department.
Disc diffusion susceptibility testing was also carried out at the time of subculture. As per laboratory protocol, discs containing 6 mg penicillin, 30 mg cefoxitin, 1 mg oxacillin, 30 mg vancomycin, 30 mg tetracycline, 15 mg erythromycin and 2 mg clindamycin were used to test all samples demonstrating Gram-positive cocci on Gram staining. In this study, susceptibility testing, both disc diffusion and broth microdilution in conjunction with the Phoenix automated identification system (Phoenix; BD Diagnostic Systems), was performed using Clinical and Laboratory Standards Institute standards and interpretation (CLSI, 2011). Blood culture broth with Gram-positive cocci resembling staphylococci upon Gram staining was subjected to the tube coagulase test using reconstituted rabbit plasma (Bio-Rad). In addition to the standard plates outlined above, blood culture broth was also inoculated on DNase test plates, trehalose fermentation agar, mannitol-salt agar and meticillin-aztreonam-mannitol-salt agar. Where identification was doubtful, the Phoenix automated system for organism identification and susceptibility testing was used, followed by the API Staph test kit (bioMérieux) or the RapID ANA II System (Remel) if uncertainties remained.
(ii) Identification of Gram-positive cocci suggestive of streptococci (including enterococci). Gram-positive cocci resembling streptococci were incubated overnight with optochin and 0.02 IU bacitracin discs (Bio-Rad) on horse blood agar. The detection of presumptive Streptococcus pneumoniae isolates, as indicated by an optochin zone diameter of greater than 14 mm, was confirmed with the Slidex pneumo-test (bioMérieux). All beta-haemolytic streptococci were grouped using the Phadebact Streptococcus grouping kit (Bactus AB). Those isolates positive for the group D antigen were preliminarily identified as Enterococcus spp. if they were also positive for pyrrolidonyl arylamidase and if growth was noted on MacConkey agar. When necessary, the Phoenix system and API 20 Strep (bioMérieux) were used to confirm identification.
VRE were identified by growth on blood agar with vancomycin (containing 4.3 mg vancomycin ml 21 ) and confirmed using the Phoenix system.
Isolates considered to be contaminants following a case review by the medical microbiology registrar were not further identified. This included most coagulase-negative staphylococci (CNS) and some alpha-and non-haemolytic streptococci.
MT-PCR
(i) Process. Eleven DNA targets were included in the Gram Positive 12 panel, plus a proprietary artificial sequence as an internal control (Table 1) . DNA copies of the rRNA pan-Staphylococcus, panStreptococcus and pan-Enterococcus sequences were targeted by these pan-primers to distinguish between the genera. This assay employed a two-step process with master mixes for both reactions provided by the manufacturer. Both steps of the assay were performed in this study as per the manufacturer's instructions.
DNA extraction was carried out by adding 20 ml blood culture broth to 180 ml G2 digestion buffer (Qiagen). Samples were then vortexed and left at room temperature for 30 min and then loaded in the EZ1
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Advanced XL instrument with the EZ1 DNA Tissue kit (Qiagen). After DNA elution in a volume of 100 ml, 10 ml was used in the step one reaction, giving a final reaction mixture volume of 20 ml.
Step one involved a short 15-cycle pre-amplification reaction using a mixture of primers homologous to each of the 11 targets and internal control. The product was then diluted into individual wells for the step two RT-PCR assays using primers nested inside the primers used for step one. The process was automated using the Easy-Plex liquid handling robotics system (AusDiagnostics).
Step two was performed in the Rotor-Gene RG6000 thermal cycler with DNA amplification measured by an increase in fluorescence as the dye Eva-Green was incorporated into DNA formed in each amplification reaction. Fluorescence was measured at the end of each 72 uC extension step with a melt curve generated at the end of cycling.
(ii) Criteria for interpretation. The internal control in the kit is a completely artificial DNA sequence that has been added to every step one tube along with the target primers. It acted as an internal control by indicating reaction inhibition where present. The melt temperature of the control product also indicated whether the reaction composition was correct. Results were disregarded unless the internal control sequence was detected with the correct melt characteristics.
When the internal control quantification cycle (C q ) was greater than 20 cycles, the result was deemed unreliable and was withheld. The analysis software (AusDiagnostics) interpreted a target as present if the melt characteristics, purity and quantity of the product conformed to preset values. Where the detection of multiple targets was necessary for species identification (e.g. Staphylococcus aureus is indicated by the detection of pan-Staphylococcus and the nuc gene, with or without the detection of the mecA gene), the C q values for each target were relatively close, indicating similar amounts of product. Any sample with a curve C q less than 10 cycles was diluted and repeated. Samples which had an internal control within 20 cycles, but with curve C q values greater than five cycles from the mean were interpreted cautiously, correlated with the Gram stain and direct coagulase results and were discussed with supervisors, and the results were withheld if still unclear.
Results were compared with those from the cultures and if discrepancies were noted, where possible, the culture was checked, MT-PCR was repeated with the same extract and, if necessary, the sample was re-extracted and retested.
(iii) Limits of detection. In addition, we attempted to ascertain the limit of detection of the Gram Positive 12 assay. Pure cultures of Streptococcus pneumoniae (ATCC 49619), Streptococcus pyogenes (ATCC 19615) and well-characterized vanB-containing E. faecium isolates and meticillin-resistant Staphylococcus aureus (MRSA) from our laboratory were obtained from inoculated plates. A 0.5 McFarland suspension, equating to approximately 1.5610 8 c.f.u. ml
21
, was prepared for each culture using PBS. Suspensions were diluted to attain a final concentration of 1.0610 3 c.f.u. ml 21 and then they were added to blood culture bottles containing human blood. These spiked samples were then extracted and the MT-PCR assay was performed as described above.
RESULTS
Over the 10-month period of study, 673 blood culture broths with Gram-positive cocci evident on Gram staining were tested in parallel with traditional culture-based methods. Cultures yielded a single organism from 625 broths and multiple organisms from 47. The culture of one broth sample did not yield viable organisms.
Monomicrobial cultures
The organisms identified by phenotypic culture methods in the monomicrobial samples and their correlations with MT-PCR results are shown in Table 2 .
(i) Staphylococci. Staphylococcus species were cultured from 476 samples, with 143 identified as Staphylococcus aureus. Forty-eight of these were MRSA as determined by traditional phenotypic methods. CNS were identified in 333 blood culture broths, with meticillin resistance detected in 210 samples. Assay inhibition (i.e. internal control was not adequately amplified in less than 20 step two cycles) affected 15/143 (10.5 %) samples containing Staphylococcus aureus and 43/333 (12.9 %) containing CNS isolates. These samples were excluded from further analysis.
Staphylococcus aureus. isolates were correctly identified to the species level by MT-PCR in all 128 (100 %) uninhibited samples, giving the pan-Staphylococcus and nuc targets a sensitivity of 100 %. However, the MT-PCR result for one sample that grew MRSA alone on culture was withheld, as DFourteen CNS samples were pan-Staphylococcus negative, with and without the detection of the mecA gene. On repeated testing with the same extracts the pan-Staphylococcus target was detected in 2/14 samples. dThe nuc gene was detected in addition to pan-Staphylococcus due to sample cross-contamination from an adjacent MSSA-positive sample. MT-PCR results were concordant with those of culture following repeat testing of the same extract. §Pan-Enterococcus, pan-Staphylococcus and the nuc gene were detected in addition to pan-Streptococcus. No contamination event was identified. Repeat test results with the same extract were concordant with culture results. # Pan-Streptococcus target was not detected in two samples from the same patient. Pan-Enterococcus was detected in two samples from the same patient due to sequence similarities with the pan-Enterococcus primer-binding site.
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the gseA target for Staphylococcus epidermidis was also detected, falsely indicating a mixed culture. The panStaphylococcus and nuc targets were detected in two samples from which Staphylococcus aureus was not cultured, giving an overall specificity of 99.5 % (426/428).
When inhibited samples were excluded, the presence or absence of meticillin resistance was correctly identified by the mecA result in all 128 (100 %) Staphylococcus aureus isolates.
Of those samples that were not inhibited, MT-PCR assay results were congruent with those of culture for 275/290 (94.8 %) CNS isolates. As can be seen in Table 2 (second footnote), the majority of discrepancies between MT-PCR and culture results were due to the pan-Staphylococcus target not being detected, with an overall sensitivity of 95.2 % (276/290). In two samples, the pan-Staphylococcus target was positive on repeat testing of the same extract. Of the 12 isolates in which MT-PCR was repeatedly negative for the pan-Staphylococcus target, seven were confirmed on culture to be CNS spp. by the Phoenix system (Staphylococcus simulans, 1; Staphylococcus capitis, 3; Staphylococcus cohnii, 1; Staphylococcus saprophyticus, 1; Staphylococcus hominis, 1). The remaining five isolates had been discarded at the time of review and could not be further processed to confirm identification, but were consistent phenotypically with CNS.
Overall concordance between culture and MT-PCR results to the species level in CNS is not reported here, as most culture isolates were considered contaminants after a medical review and were not processed to the species level.
MT-PCR detected meticillin resistance in CNS with accuracy, with a sensitivity of 99.4 % (180/181) and specificity of 99.1 % (108/109).
(ii) Streptococci. Streptococcus species were cultured from 91 blood culture broths, with 16 isolates identified as Streptococcus pneumoniae (Table 2) . Assay inhibition was evident in 2/16 (12.5 %) samples from which Streptococcus pneumoniae was cultured. MT-PCR showed 100 % sensitivity in the identification of Streptococcus pneumoniae in the remaining 14 samples, with 100 % specificity.
Streptococcus species other than Streptococcus pneumoniae were cultured from 75 samples. MT-PCR assay inhibition affected five (6.7 %) samples. In the remaining 70 samples, culture and MT-PCR results were concordant in 67/70 (95.7 %). The range of streptococcal species cultured and the errors in the MT-PCR identification in this group are outlined in Table 2 .
(iii) Enterococci. Enterococcus species were cultured from 34 blood culture broths (Table 2) . MT-PCR assay inhibition affected 4/34 (11.8 %) samples. Of the remaining samples, culture and MT-PCR results were congruent for the identification of E. faecium and E. faecalis in all 30 (100 %) cases.
Vancomycin resistance in VRE isolates in this study was mediated by the vanB gene. When inhibited samples were excluded, the assay correctly detected the presence or absence of vancomycin resistance in all eight (100 %) E. faecium isolates.
(iv) Miscellaneous pathogens. Twenty-five additional samples had Gram-positive cocci present on Gram staining. A single bacterial or yeast isolate was cultured from 24 of these samples as demonstrated in Table 2 . One sample was non-viable on culturing. Assay inhibition affected 1/25 (4.0 %) samples. The MT-PCR results for 22/24 (91.7 %) of the remaining samples were in agreement with those of culture, in that none of the bacterial targets were detected. Discordance between MT-PCR and culture results was seen in two samples from a single patient (two aerobic bottles) that were identified as Granulicatella adiacens on culture. These were incorrectly identified as Enterococcus spp. by the assay (pan-Enterococcus positive) due to recognized similarities with the pan-Enterococcus primer-binding site (Table 2 , sixth footnote).
Polymicrobial cultures
Culture results yielded a mixture of bacteria in 47 blood culture broths. MT-PCR assay inhibition affected 9/47 (19.1 %) samples. MT-PCR identifications were in agreement with those of culture in 36/38 (94.7 %) of the remaining samples, as demonstrated in Table 3 . In addition, while identification was in concordance with culture results, the mecA target was detected in one sample with mixed oxacillin-sensitive CNS, possibly due to crosscontamination from an adjacent sample.
Limits of detection
The Gram Positive 12 MT-PCR assay correctly detected the expected genes for each prepared sample, indicating a sensitivity of at least 1.0610 3 c.f.u. ml 21 in this study. No further dilutions were performed.
DISCUSSION
In this study we have demonstrated the utility of a commercially available MT-PCR assay in the rapid identification of Gram-positive organisms directly from positive blood culture broths. When inhibited samples were excluded, the Gram Positive 12 MT-PCR assay yielded results that matched those of phenotypic bacterial identification to the genus level in 96.6 % (537/556) of monomicrobial specimens and to the species level, where applicable, in 100 % (172/172) of samples. MT-PCR results for 94.7 % of uninhibited polymicrobial samples matched those of traditional phenotypic bacterial identification methods. These results exceed the 90 % accuracy limit proposed as a minimum requirement for the employment of new bacterial identification systems in laboratories handling clinical samples (Petti et al., 2011) .
Contemporary studies using multiplex RT-PCR assays on positive blood culture broths with Gram-positive organisms have typically included molecular targets only for speciation of Staphylococcus species and detection of meticillin resistance. Our data, with 100 % sensitivity for the detection of Staphylococcus aureus and mecA, are similar to contemporary work with the various RT-PCR assays employed in previously published studies detecting meticillin-sensitive Staphylococcus aureus (MSSA) and MRSA, with sensitivities of 100 % and between 97.9 and 100 %, respectively (Paule et al., 2005; Parta et al., 2009; Wolk et al., 2009; Jukes et al., 2010) . The MT-PCR assay described here has the added advantage of also being a rapid and accurate diagnostic tool for the detection of Streptococcus pneumoniae and Enterococcus species, including VRE.
In clinical practice, earlier identification of causative organisms in Gram-positive bacteraemia and their associated antibiotic-sensitivity patterns can lead to an earlier initiation of targeted antibiotic therapy, which may impact favourably on patient outcomes and lower costs (Khatib et al., 2006; Kumar et al., 2006) . In addition, the earlier use of targeted antibiotic therapy is one of a number of approaches needed to slow the development of antibiotic resistance; of particular importance in the current age where the development of antibiotic resistance outweighs the development of new antimicrobials (Livermore et al., 2011) .
The major limitation encountered in this evaluation was the relatively high incidence of assay inhibition, involving 11.2 % (70/626) of monomicrobial samples and 19.1 % (9/ 47) of polymicrobial samples. Both aerobic and anaerobic blood culture broths were affected. PCR inhibition by blood culture bottle contents such as sodium polyanethol sulfonate and whole blood components including haemoglobin, lactoferrin and immunoglobulins is well described (Regan et al., 2012) . These inhibited tests add to the overall costs, with each test costing approximately *Pan-Enterococcus was also positive. We were unable to retrieve cultures to confirm identification. Possible primer mismatch or all isolates were not fully identified. DPan-Staphylococcus was not detected.
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$30 AUD plus the cost of extraction and labour. As a result, different methods of extraction are currently being explored.
Other limitations of the Gram Positive 12 MT-PCR assay include a minor drop in sensitivity due to the panStaphylococcus primer's failure to detect CNS in samples. In the current study, the pan-Staphylococcus MT-PCR target was not detected initially in 14 of 290 CNS isolates.
A low background pan-Enterococcus signal was also noted in approximately 9 % of samples, thought to be secondary to cross-reactions between this primer and target-binding sites. For the majority of these samples, the panEnterococcus C q was easily identifiable as a late positive (i.e. .20 cycles) and the activity was disregarded. A reduction in the specificity of the assay is recognized to occur with Facklamia languida and G. adiacens due to sequence similarities with the binding site for the panEnterococcus primer. These, however, are uncommon isolates and are unlikely to contribute significantly to reporting errors in a working laboratory.
In addition, while this assay was very accurate at detecting meticillin resistance secondary to the mecA gene, variants such as emerging mecC-positive MRSA would not be detected due to substantial sequence differences. mecCpositive MRSA, however, is rare at present and its detection is a problem that would affect most, if not all, commercial and in-house molecular assays designed to detect mecAderived meticillin resistance (Laurent et al., 2012) .
From the time at which a blood culture signalled positive bacterial growth, a MT-PCR result was achievable within 3 h, which compares favourably with the 24-48 h time period generally required to perform traditional phenotypic culture methods. Gram Positive 12 MT-PCR discs are available that require only three samples, so while samples were batched during this evaluation, for the most part, this did not introduce a significant delay in processing, as a high number of blood cultures are processed in our laboratory 24 h a day. In this assay validation, results were not routinely notified to clinicians and we were thus unable to assess the impact that the earlier provision of information on pathogen identification and antibiotic resistance had on clinical management and infection control practices. However, the Gram Positive 12 MT-PCR assay has subsequently been successfully integrated into the blood culture work algorithm at our laboratory and is a useful adjunct in the rapid and accurate identification of Gram-positive pathogens such as Staphylococcus aureus, Streptococcus pneumoniae and Enterococcus species and their common antimicrobial resistance genes.
